NCT02223351View on ClinicalTrials.gov

Drug-Drug Interaction Study: ASP2151 and Ritonavir

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy
Interventions
DRUG

ASP2151

DRUG

ritonavir

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research Ltd, London

All Listed Sponsors
lead

Maruho Europe Limited

INDUSTRY

NCT02223351 - Drug-Drug Interaction Study: ASP2151 and Ritonavir | Biotech Hunter | Biotech Hunter